These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21849697)

  • 1. Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.
    Kok J; Wang Q; Thomas LC; Gilbert GL
    J Clin Microbiol; 2011 Oct; 49(10):3719-21. PubMed ID: 21849697
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
    Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
    J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.
    Barbut F; Monot M; Rousseau A; Cavelot S; Simon T; Burghoffer B; Lalande V; Tankovic J; Petit JC; Dupuy B; Eckert C
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1279-85. PubMed ID: 21487764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
    Dalpke AH; Hofko M; Zorn M; Zimmermann S
    J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the tcdA gene: is this appropriate for detection of A and/or B Clostridium difficile toxin-producing strains?
    Kozak K; Elagin V; Norén T; Unemo M
    J Clin Microbiol; 2011 Jun; 49(6):2383; author reply 2383-4. PubMed ID: 21617002
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
    Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
    J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual cause of false-positive results with the BD GeneOhm Cdiff assay.
    Louie L; Wong H; Mubareka S; Simor AE
    J Clin Microbiol; 2013 Apr; 51(4):1348-9. PubMed ID: 23345300
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.
    Lalande V; Barrault L; Wadel S; Eckert C; Petit JC; Barbut F
    J Clin Microbiol; 2011 Jul; 49(7):2714-6. PubMed ID: 21525213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of strain typing results for Clostridium difficile isolates from North America.
    Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
    J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
    Deak E; Miller SA; Humphries RM
    J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
    Cohen J; Limbago B; Dumyati G; Holzbauer S; Johnston H; Perlmutter R; Dunn J; Nadle J; Lyons C; Phipps E; Beldavs Z; Clark LA; Lessa FC;
    J Clin Microbiol; 2014 Feb; 52(2):632-4. PubMed ID: 24478500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.
    Huang H; Weintraub A; Fang H; Nord CE
    J Clin Microbiol; 2009 Nov; 47(11):3729-31. PubMed ID: 19741082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
    Shin BM; Mun SJ; Yoo SJ; Kuak EY
    J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
    Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
    Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
    Nolte FS; Ribeiro-Nesbitt DG
    J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.